Humana Stock Falls Despite Strong Q1 Earnings as Profit Forecast Unchanged

Humana's stock declined after the health insurer maintained its full-year profit forecast, disappointing investors who had anticipated a guidance raise following a strong first quarter. The company's first-quarter benefit ratio, a key metric measuring medical costs against premiums, came in better than expected at 84.5%, below the 85.1% consensus estimate. However, Humana kept its 2026 adjusted earnings per share outlook at $26.00, citing uncertainty around Medicare Advantage reimbursement rates and utilization trends. The stock fell 4.2% in early trading, reflecting investor disappointment that the company did not raise its guidance despite the Q1 beat. Analysts noted that while the quarter was solid, the lack of an upward revision suggests management remains cautious about the remainder of the year. Humana's Medicare Advantage business, which accounts for the majority of its revenue, faces ongoing regulatory headwinds and potential changes to payment models. The company reported Q1 revenue of $29.3 billion, up 12% year-over-year, driven by membership growth in its individual Medicare Advantage plans. Despite the earnings beat, the market's focus on the unchanged forecast underscores the high expectations for health insurers in the current environment.